phase

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

October 31, 2025 16:30 ET  | Source: FibroBiologics, Inc. Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628,…

4 weeks ago

Hyundai Motor Group Announces NVIDIA Blackwell AI Factory to Power Fleet of AIDriven Mobility Solutions

Hyundai Motor Group and NVIDIA will collaborate with the Korean government to develop Korea’s physical AI industry, including the establishment…

4 weeks ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

4 weeks ago

Mutuum Finance (MUTM) Approaches Phase 6 Sell-Out With Investor Participation Surpassing 17,400 Holders

Dubai, UAE, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM) continues to make headlines in the crypto market as it…

1 month ago

Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future

As Shanghai Electric's fourth photovoltaic project in Romania, this initiative marks a major step forward for the country's clean energy…

1 month ago

DeFi Crypto Mutuum Finance Completes Phase 1 Roadmap as V1 Protocol Launch Approaches

Dubai, UAE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market begins shifting its focus back to fundamentals, one…

1 month ago

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…

1 month ago

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium

Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, announced analyses data…

1 month ago

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

October 24, 2025 07:02 ET  | Source: Kura Oncology, Inc. - Milestone triggered by dosing of first patient in frontline…

1 month ago

Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference

October 24, 2025 07:00 ET  | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…

1 month ago